Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 2 Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 49 Rectal Neoplasms 29 Pancreatic Neoplasms 25 Colonic Neoplasms 25 Neoplasm Metastasis 19 Stomach Neoplasms 17 Neoplasms 17 Esophageal Neoplasms 17 Head and Neck Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Breast Neoplasms 10 Adenocarcinoma Of Esophagus 8 Esophageal Squamous Cell Carcinoma 6 Cholangiocarcinoma 6 Carcinoma, Squamous Cell 6 Gallbladder Neoplasms 5 Carcinoma, Hepatocellular 5 Bile Duct Neoplasms 5 Liver Neoplasms 4 Anus Neoplasms 4 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Somatostatinoma 2 Sarcoma 2 Peritoneal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

iadademstat 1 Temozolomide 1 Sunitinib 1 Paclitaxel 1 PE regimen 1 Irinotecan 1 Fluorouracil 1 Everolimus 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Neuroendocrine × Fluorouracil × Clear all

NCT03387592 2025-03-10

SENECA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡